Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05649228 · ClinicalTrials.gov registry record · Early Phase 1
Thermosensitivity of a Topical Palmitated Formulation of Capsaicin
A Early Phase 1 study, sponsored by Carilion Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 52
- Enrollment target
NCT05649228 is a Early Phase 1 study that has completed, run by Carilion Clinic. The registered enrollment target is 52 participants.
The verdict
NCT05649228, a Early Phase 1 study, has completed, sponsored by Carilion Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
This is a study of the effects of capsaicin, the ingredient that makes hot peppers hot. Capsaicin is currently used in topical ointments to provide temporary relief of minor aches and joint pain associated with arthritis, simple backache, strains, and sprains. This is a pilot research study that compares the potential of two different capsaicin creams to cause irritation or burning sensation when a small amount (about the size of a quarter) is applied to each forearm of a participant. The amount of capsaicin used in the creams is the same as those found in over-the-counter capsaicin products. The test creams are experimental.
Interventions
- DRUG Placebo Cream
- DRUG Capsaicin 0.1% Cream
- DRUG Capsaicin Palmitate 0.25% Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2024-01-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05649228
The ClinicalTrials.gov registry entry for NCT05649228 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Cream is the first listed.
NCT05649228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05649228 about?
NCT05649228 is a clinical study titled "Thermosensitivity of a Topical Palmitated Formulation of Capsaicin". This is a study of the effects of capsaicin, the ingredient that makes hot peppers hot. Capsaicin is currently used in topical ointments to provide temporary relief of minor aches and joint pain associated with arthritis, simple backache, strains, and sprains. This is a pilot research study that co...
What is the current status of trial NCT05649228?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 52 participants. The study started on 2022-12-13. Estimated completion is 2024-01-11.
What interventions are being tested in trial NCT05649228?
The interventions under investigation include: Placebo Cream (DRUG), Capsaicin 0.1% Cream (DRUG), Capsaicin Palmitate 0.25% Cream (DRUG).
Who is sponsoring clinical trial NCT05649228?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.